vs
Strive, Inc.(ASST)与Chime Financial, Inc.(CHYM)财务数据对比。点击上方公司名可切换其他公司
Chime Financial, Inc.的季度营收约是Strive, Inc.的2131.4倍($543.5M vs $255.0K)。Chime Financial, Inc.净利率更高(-10.1% vs -75406.7%,领先75396.6%)。Chime Financial, Inc.同比增速更快(28.8% vs -74.1%)
斯特赖夫资产管理是一家2022年成立的美国投资管理机构,总部位于俄亥俄州哥伦布市,是斯特赖夫企业股份有限公司旗下子公司。该机构提供共同基金、交易所交易产品以及财富管理服务,是美国证监会注册的投资顾问。
Chime Financial, Inc.是总部位于美国加利福尼亚州旧金山的金融科技企业,通过与Stride Bank、The Bancorp Bank两家全国性银行合作,为用户提供免服务费的移动银行服务,是美国消费金融科技领域的代表性企业之一。
ASST vs CHYM — 直观对比
营收规模更大
CHYM
是对方的2131.4倍
$255.0K
营收增速更快
CHYM
高出102.9%
-74.1%
净利率更高
CHYM
高出75396.6%
-75406.7%
损益表 — Q3 2025 vs Q3 2025
| 指标 | ||
|---|---|---|
| 营收 | $255.0K | $543.5M |
| 净利润 | $-192.3M | $-54.7M |
| 毛利率 | — | 87.2% |
| 营业利润率 | -17288.6% | -11.9% |
| 净利率 | -75406.7% | -10.1% |
| 营收同比 | -74.1% | 28.8% |
| 净利润同比 | -2726.9% | -148.4% |
| 每股收益(稀释后) | $-0.22 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASST
CHYM
| Q3 25 | $255.0K | $543.5M | ||
| Q2 25 | $173.3K | $528.1M | ||
| Q1 25 | $170.7K | — | ||
| Q4 24 | $212.8K | — | ||
| Q3 24 | — | $421.9M | ||
| Q2 24 | $93.0K | $384.2M | ||
| Q1 24 | $124.8K | — | ||
| Q4 23 | $80.9K | — |
净利润
ASST
CHYM
| Q3 25 | $-192.3M | $-54.7M | ||
| Q2 25 | $-8.9M | $-923.4M | ||
| Q1 25 | $-3.7M | — | ||
| Q4 24 | $-4.1M | — | ||
| Q3 24 | — | $-22.0M | ||
| Q2 24 | $-5.9M | $385.0K | ||
| Q1 24 | $-4.8M | — | ||
| Q4 23 | $-1.3M | — |
毛利率
ASST
CHYM
| Q3 25 | — | 87.2% | ||
| Q2 25 | — | 87.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 87.3% | ||
| Q2 24 | — | 86.9% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
营业利润率
ASST
CHYM
| Q3 25 | -17288.6% | -11.9% | ||
| Q2 25 | -1553.9% | -176.2% | ||
| Q1 25 | -970.5% | — | ||
| Q4 24 | -5889.5% | — | ||
| Q3 24 | — | -7.3% | ||
| Q2 24 | -1857.2% | -2.5% | ||
| Q1 24 | -1110.9% | — | ||
| Q4 23 | -1667.7% | — |
净利率
ASST
CHYM
| Q3 25 | -75406.7% | -10.1% | ||
| Q2 25 | -5122.4% | -174.8% | ||
| Q1 25 | -2195.6% | — | ||
| Q4 24 | -1935.5% | — | ||
| Q3 24 | — | -5.2% | ||
| Q2 24 | -6313.1% | 0.1% | ||
| Q1 24 | -3837.7% | — | ||
| Q4 23 | -1667.7% | — |
每股收益(稀释后)
ASST
CHYM
| Q3 25 | $-0.22 | $-0.15 | ||
| Q2 25 | $-0.17 | $-7.29 | ||
| Q1 25 | $-0.13 | — | ||
| Q4 24 | $-5.62 | — | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | $-0.58 | $0.00 | ||
| Q1 24 | $-0.49 | — | ||
| Q4 23 | $-0.88 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $109.1M | $445.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.4M | $1.4B |
| 总资产 | $792.6M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASST
CHYM
| Q3 25 | $109.1M | $445.0M | ||
| Q2 25 | $2.5M | $868.3M | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $6.2M | — | ||
| Q3 24 | — | $270.8M | ||
| Q2 24 | $1.9M | $295.4M | ||
| Q1 24 | $1.9M | — | ||
| Q4 23 | $2.9M | — |
股东权益
ASST
CHYM
| Q3 25 | $779.4M | $1.4B | ||
| Q2 25 | $10.7M | $1.4B | ||
| Q1 25 | $19.6M | — | ||
| Q4 24 | $23.3M | — | ||
| Q3 24 | — | $-1.9B | ||
| Q2 24 | $5.4M | $-1.9B | ||
| Q1 24 | $11.3M | — | ||
| Q4 23 | $16.1M | — |
总资产
ASST
CHYM
| Q3 25 | $792.6M | $2.0B | ||
| Q2 25 | $3.3M | $1.9B | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $28.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $2.4M | — | ||
| Q1 24 | $2.1M | — | ||
| Q4 23 | $3.1M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-14.0M | $17.5M |
| 自由现金流经营现金流 - 资本支出 | — | $15.4M |
| 自由现金流率自由现金流/营收 | — | 2.8% |
| 资本支出强度资本支出/营收 | 0.0% | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ASST
CHYM
| Q3 25 | $-14.0M | $17.5M | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | $-6.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.3M | — | ||
| Q1 24 | $-1.0M | — | ||
| Q4 23 | $-854.1K | — |
自由现金流
ASST
CHYM
| Q3 25 | — | $15.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-6.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.3M | — | ||
| Q1 24 | $-1.1M | — | ||
| Q4 23 | — | — |
自由现金流率
ASST
CHYM
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2937.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1379.4% | — | ||
| Q1 24 | -844.7% | — | ||
| Q4 23 | — | — |
资本支出强度
ASST
CHYM
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 82.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 9.5% | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASST
暂无分部数据
CHYM
| Payments Revenue | $363.2M | 67% |
| Platform Related Revenue | $180.4M | 33% |